Graham Collins, MBBS, on New Agents, Prognostic Models in Hodgkin Lymphoma
The HemOnc Pulse
00:00
Checkpoint Inhibitors in Hodgkin Lymphoma
The use of checkpoint inhibitors depends on the TPS score, CPS score and all of that. Is that similar in Hodgkin lymphoma? There's been quite a bit of work on that done. It's mainly been done at just PDL1 expression on Reed Sternberg cells. And there is a correlation, but it's not that strong.
Transcript
Play full episode
